维普中文期刊产品整合服务
192篇 您的检索式:作者名="ESSER S"
    题名 作者 年代 出处 被引量
1Cetuximab plus FOLFOX6 or FOLFIRI in metastatic colorectal cancer: CECOG trial显示文摘AIM: To investigate efficacy and safety of cetuximab combined with two chemotherapy regimens in patients with unresectable metastatic colorectal cancer (mCRC). METHODS: Randomized patients received cetuximab with 5-fluorouracil (5-FU), folinic acid (FA) and oxaliplatin (FOLFOX) 6 (arm A, n = 74) or 5-FU, FA and irinotecan (FOLFIRI) (arm B, n = 77). KRAS mutation status was determined retrospectively in a subset of tumors (n = 117). RESULTS: No significant difference was found between treatment arms A and B in the progression-free survival (PFS) rate at 9 mo, 45% vs 34%; median PFS, 8.6 mo vs 8.3 mo [hazard ratio (HR) = 1.06]; overall response rate (ORR) 43% vs 45% [odds ratio (OR) = 0.93] and median overall survival (OS), 17.4 mo vs 18.9 mo (HR = 0.98). Patients with KRAS wild-type tumors demonstrated improved PFS (HR = 0.55, P = 0.0051), OS, (HR = 0.62, P = 0.0296) and ORR (53% vs 36%) and in arm A, improved PFS (HR = 0.49, P = 0.0196), OS (HR = 0.48, P = 0.0201) and ORR (56%vs 30%), compared with patients with KRAS mutated tumors. In arm B no significant differences were found in efficacy by KRAS mutation status. Treatment in arms A and B was generally well tolerated. CONCLUSION: This study confirms that combinations of cetuximab with FOLFOX6 or FOLFIRI are effective and significantly improve clinical outcome in KRAS wild-type compared with KRAS mutated mCRC.Janja Ocvirk Thomas Brodowicz Fritz Wrba Tudor E Ciuleanu Galina Kurteva Semir Beslija Ivan Koza Zsuzsanna Pápai Diethelm Messinger Ugur Yilmaz Zsolt Faluhelyi Suayib Yalcin Demetris Papamichael Miklós Wenczl Zrinka Mrsic-Krmpotic Einat Shacham-Shmueli Damir Vrbanec Regina Esser Werner Scheithauer Christoph C Zie-linski 2010World Journal of Gastroenterology2010,16,25:17
2Antiproliferative Wirkung von genistein auf kuhivierte retinale Pigmentepithelzellen vom Schwein显示文摘Krott R Lebek J Grisanti S Esser P Heimann K 2000Olgatlmlmologica2000,214,4:1
3Vascular endothelial growth factor induces endothelial fenestrations in vitro显示文摘Esser S Wolburg K Wolburg H 1998J Cell Bid1998,140,4:1
4Pre operative MRI and surgical management in patients with nonpalpa ble breast cancer:the MONET-randomised controlled trial显示文摘Peters NH van Esser S van den Bosch MA 2011Eur J Cancer2011,47,6:1
5Cognitive Computing显示文摘Modha D S Ananthanarayanan R Esser S K 2011Communications of the ACM (S0001-0782)2011,54,8:1
6The Development of the PVD Coating TiAlV as a Commercial Coating for Cutting Tools 显示文摘Leyendecker T Lemmer O Esser S 1991Surf Coat Technol1991,,48:1
7Preop- erative MRI and surgical management in patients with nonpalpable breast cancer:the MONET-randomised con- trolled trial 显示文摘Peters NH van Esser S van den Bosch MA 2011Eur J Cancer2011,47,6:1
8Illuminating the evolutionary history of chlamydiae 显示文摘Horn M Collingro A Schmitz - Esser S 2004Science2004,304,5671:1
9IF-Nalpha activates dormant haematopoietic stem cells in vivo 显示文摘ESSERS M A OFFNER S BLANCO-BOSE W E 2009Nature2009,458,:1
10The psychometric properties of the St George's Respiratory Questionnaire(SGRQ)in patients with idiopathic pulmonary fibrosis:a literature review显示文摘Swigris J J Esser D Conoscenti C S 2014Health Qual Life Outcomes2014,12,1:1
11Waterbased crosslinkable surface coatings 显示文摘RICHARD J ESSER JAMES E DEVONA DAVE E S 1999Progress in Organic Coatings1999,,36:1
12The efficacy of radio guided occult lesion localization'(ROLL)versus'wireguided localization'(WGL)in breast conserving surgery for nonpalpable breast cancer:a randomized clinical trial-ROLL study显示文摘Esser S Hobbelink MG Peeters PH 2008BMC Surg2008,8,1:1
13Dosimetric accuracy andclinical quality of Acuros XB and AAA dose calculation algorithmfor stereotactic and conventional lung volumetric modulated arctherapy plans显示文摘KROON P S HOL S ESSERS M 2013Radiat Oncol2013,8,:1
14Fractures of the radial head treated by internal fixation:late results in 26 cases显示文摘Esser RD Davis S Taavao T 1995J Orthop Trauma1995,,9:1
15Progression of coronary atheroscleroeic disease assessed by cine videodensitometry: relation to clinical risk factor 显示文摘SHEA S SCIACCA R R ESSER P 1986Am J Cardio1986,57,8:1
16IFNalpha activates dormant haematopoietic stem cells in vivo 显示文摘Essers MA Offner S Blanco-Bose WE 2009Nature2009,458,7240:1
17Beta 2- microglobulin stimulates osteoclast formation显示文摘Menaa C Esser E Sprague S 2008Kidney Int2008,73,11:1
18self-administered topical 5% imiquimod for the treatment of common wards and molluscum contagiosum显示文摘Hengge UR Esser S Schultewolter T 2000Br J Dermatol2000,143,5:1
19Prevalence of cardiac dias- tolic dysfunction in HIV-infected patients: results of the HIV- HEART study显示文摘Reinsch N Neuhaus K Esser S etal 2010HIV Clin Trials2010,11,3:1
20Preoperative MRI and surgical management in patients with nonpalpable breast cancer:the MONET-randomised controlled trial显示文摘Peters N Van Esser S van den Bosch M 2011Euro J Canc- er2011,47,6:1
返回顶部 每页显示:
共10页 首页 上一页 第1页 下一页 末页 /10 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费